Description

Overview

This kit pairs Hexarelin and CJC-1295 (no DAC) for research on the growth hormone axis. It combines a GHRH analog with a ghrelin receptor agonist (GHRP), two compound classes that act through separate pathways and are studied together for their synergistic effect on growth hormone release.

Peptide Sciences Bio supplies Hexarelin + CJC-1295 (no DAC) Kit (2mg, 10 + 10 vials) as a multi-vial research kit containing separately packaged vials of Hexarelin and CJC-1295 (no DAC) for in-vitro and preclinical laboratory investigation. Supplying the compounds in separate vials lets researchers control each one independently. Every batch is supported by independent analytical testing and a published Certificate of Analysis.

Product Specifications

ProductHexarelin + CJC-1295 (no DAC) Kit (2mg, 10 + 10 vials)
FormatMulti-vial kit, compounds in separate vials
Contents10 × 2mg hexarelin and 10 × 2mg CJC-1295 no DAC, 20 vials total
Hexarelin CAS140703-51-1
CJC-1295 (no DAC) CAS863288-34-0
FormLyophilized powder
Purity≥99% per component (HPLC)
DocumentationBatch-specific Certificate of Analysis

Components

  • Hexarelin: a potent synthetic hexapeptide GHRP that also binds the cardiac receptor CD36.
  • CJC-1295 (no DAC): a modified 29-amino-acid GHRH analog that activates the GHRH receptor on pituitary somatotrophs.

Note: Mod GRF 1-29 and CJC-1295 (no DAC) are two names for the same compound.

GHRH and GHRP Synergy

Growth hormone release is controlled by two main stimulatory signals. GHRH acts on the GHRH receptor and raises cAMP in pituitary somatotrophs. Ghrelin and the synthetic GHRPs act on a separate receptor, GHS-R1a, which works through calcium signaling and also counteracts somatostatin, the hormone that suppresses GH release. Because they use different pathways, research has consistently found that combining a GHRH analog with a GHRP produces a greater GH response than either compound alone, often more than the sum of the two. This synergy is the main reason these compounds are studied together.

Mechanisms Studied

  • Hexarelin: strong GH release through GHS-R1a.
  • CJC-1295 (no DAC): binding to the GHRH receptor on pituitary somatotroph cells and cAMP signaling.

Areas of Study

  • Growth hormone secretion and pulsatility research
  • GHRH and ghrelin receptor combination pharmacology
  • IGF-1 axis research
  • Body composition research models

These findings come from laboratory, animal and clinical pharmacology research on the individual components. This research-grade product is not an approved drug product and is not intended for human use.

Related Research Peptides

Quality & Testing

Every batch of this kit is independently tested for identity and purity before release. Testing includes high-performance liquid chromatography (HPLC) to confirm purity and mass spectrometry (MS) to confirm molecular identity. The batch-specific Certificate of Analysis is available on this page and in our COA library, so researchers can verify the exact material they receive.

Storage & Handling

  • Store lyophilized this kit at −20°C, protected from light and moisture.
  • Short-term storage at 2–8°C is acceptable for lyophilized material.
  • Allow the vial to reach room temperature before opening to limit condensation.
  • Handle using standard laboratory practices and appropriate protective equipment.

For laboratory solution preparation, see our Peptide Reconstitution Guide.

Frequently Asked Questions

What is in the Hexarelin + CJC-1295 (no DAC) Kit (2mg, 10 + 10 vials)?

It contains Hexarelin and CJC-1295 (no DAC) in separate vials: 10 × 2mg hexarelin and 10 × 2mg CJC-1295 no DAC, 20 vials total.

Why are these compounds studied together?

GHRH analogs and GHRPs stimulate growth hormone release through different receptors, and research shows that combining them produces a synergistic response.

Why separate vials instead of a pre-mixed blend?

Separate vials let researchers prepare and adjust each compound independently.

Is this product approved for human use?

No. This product is a research-grade material, not an approved drug product, and is not intended for human or veterinary use. Peptide Sciences Bio sells it strictly for laboratory research.

How should it be stored?

Store the lyophilized material at −20°C, away from light and moisture. Short-term storage at 2–8°C is acceptable.

Research Use Only

This product is intended solely for in-vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, supplement or cosmetic, and it is not intended for human or veterinary use, or for the diagnosis, treatment or prevention of any condition. Purchase is restricted to buyers who agree to our Terms of Sale.

Additional information​

Product FormLyophilized Powder (Vial)

Hexarelin (2mg x 10), CJC-1295 no DAC (2mg x 10)

Original price was: $552.50.Current price is: $499.00.

Hexarelin + CJC-1295 (no DAC) Kit (2mg, 10 + 10 vials) is a multi-vial research kit containing separately packaged vials of Hexarelin and CJC-1295 (no DAC) (10 × 2mg hexarelin and 10 × 2mg CJC-1295 no DAC, 20 vials total), designed for preclinical research on the synergy between GHRH and ghrelin receptor signaling in growth hormone release. Each component is ≥99% pure (HPLC), with batch-specific COA available. For laboratory research use only.

Shipping & 30 Days Return

Worldwide tracked delivery. Dispatched within 24 hours of order confirmation.

Not satisfied? Return any item within 10 days for a full refund, no questions asked.